Related Experiment Video
Updated: Oct 11, 2025

06:32
Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures
Published on: January 9, 2019
8.0K
Cilium Expression Score Predicts Glioma Survival.
Srinivas Rajagopalan1, Amartya Singh1, Hossein Khiabanian1,2
1Center for Systems and Computational Biology, Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ, United States.
Frontiers in Genetics
|December 6, 2021
Summary
Biclustering analysis of 1,798 brain samples identified gene expression profiles linked to glioma characteristics. A cilium-associated gene signature predicts poor survival, offering potential therapeutic targets for aggressive gliomas.
Area of Science:
- Neuro-oncology
- Genomics
- Computational Biology
Background:
- Glioma heterogeneity complicates accurate classification, prognostication, and treatment.
- Traditional clustering methods struggle with complex glioma heterogeneity.
- Biclustering offers a novel approach to identify co-regulated genes within sample subsets.
Purpose of the Study:
- To apply unsupervised biclustering to analyze gene expression in normal and tumor brain samples.
- To identify novel gene expression profiles associated with glioma characteristics and clinical outcomes.
- To investigate the role of cilia in glioma development and progression.
Main Methods:
- Unsupervised biclustering analysis of 1,798 normal and tumor brain samples.
- Identification of co-regulated gene expression profiles.
- Development of a risk score based on 12 cilium-associated genes.
Main Results:
- Co-regulated gene expression profiles linked to brain regions and glioma histologic grade were identified.
- Upregulated genes in subsets of gliomas correlated with clinical outcome.
- A cilium-associated gene signature was found to be predictive of poor survival.
- A 12-gene risk score demonstrated reproducible prognostic value independent of other biomarkers.
Conclusions:
- Cilia play a significant role in glioma development and progression.
- The identified cilium-associated signature and risk score offer prognostic insights.
- These findings suggest potential therapeutic vulnerabilities in aggressive gliomas.

